New York, USA, June 22, 2022 (GLOBE NEWSWIRE) -- Transplant Diagnostics Market Overview
According to a Comprehensive Research Report by Market Research Future (MRFR), “Transplant Diagnostics Market Information By Product & Service, Screening Type, Organ Type, And Region - Forecast till 2030", the market will touch USD 7.42 billion by 2030, a 7.8% CAGR.
Transplant Diagnostics Market Synopsis
Transplant diagnostics are used to determine whether the donor and receiver of an organ are compatible before or after transplantation. With the adoption of transplant diagnostics, the surging prevalence of diseases that can lead to organ failure, including both pre-and post-transplant screening, is predicted to skyrocket. Due to the multiple benefits offered by these tests to check the suitability of the organ transplant procedure, the market has piqued the interest of healthcare practitioners. For example, in the situation of heart transplants, diagnostics related to pulmonary function and general health receive much attention. Diagnostics have advanced dramatically over the last decade, thanks to firms' commitment to creating better antibody monitoring, HLA typing technologies, instruments, and software.
For many individuals with end-stage renal illness on continuous dialysis, transplantation is one of the most recommended therapeutic alternatives. In addition, transplantation is a possible option to explore in cases involving the heart, liver, or bone marrow. Although in many cases, there is a strong link between kidney malfunction and liver transplantation, including end-stage renal disease. New transcriptomic, proteomic, and genomic indicators in molecular diagnostics can help with better-customized organ transplant therapy and early detection of rejection events.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/1324
Report Scope:
| Report Attribute | Details |
| Market Size | USD 7.42 billion |
| CAGR | 7.8% |
| Base Year | 2021 |
| Forecast Period | 2022-2030 |
| Historical Data | 2020 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Product & Service, Screening Type, Organ Type and Application |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Market Drivers | Growing Incidence of Organ Failure to Favor the Market |
| Rising adoption of stem cell therapy and customized drugs is gaining a reputation |
Transplant Diagnostics Market Competitive Landscape:
The distinguished contenders in the transplant diagnostic market are:
- Immucor Transplant Diagnostics Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Hoffman-La Roche Ltd. (Switzerland)
- GenDx (Netherlands)
- CareDx (U.S.)
- Affymetrix Inc. (U.S.)
- Linkage Biosciences (U.S.)
- Becton Dickinson and Company (U.S.)
- Bio-Rad Inc. (U.S.)
- Illumina Inc. (U.S.)
- Abbott Laboratories Inc. (U.S.)
- bioMérieux S.A. (France)
- QIAGEN NV (Netherlands)
- Omixon Ltd. (U.K.)
Transplant Diagnostics Market USP Covered:
Market Drivers:
The increased prevalence of chronic illnesses among the worldwide population is likely to drive market expansion throughout the forecast years. Furthermore, the increasing use of stem cell therapy and personalized medications is gaining popularity. The use of new diagnostic techniques has improved the medical outcomes of organ transplants. The rate of organ rejection can be reduced by matching the compatibility of the donor and recipient before transplantation.
Furthermore, an increase in the number of patients with organ failure is driving greater demand for transplant procedures. Furthermore, tailored medicine is becoming more popular. As a result, pre-procedure diagnostics are becoming increasingly popular. The risks and difficulties of organ transplantation need the development of more advanced diagnostic techniques. The companies' current prospects and obstacles are affordability, technological developments regarding reagent effectiveness, clinician decision-making and raising awareness, and suitable organ preservation facilities.
Market Restraints:
The high cost of procedures associated with PCR and NGS diagnostic instruments is one of the most significant. As a result, market growth may be hampered in the long run. The cost of medical equipment is one element that may provide a challenge to critical transplant diagnosis device vendors. The widening gap between organ donors and transplantation operations is a significant concern for market players. In addition, the transplant diagnostics industry is expected to be challenged by a considerable disparity between the number of organ donors and the number of organs required annually.
Browse In-depth Market Research Report (100 Pages) on Transplant Diagnostics: https://www.marketresearchfuture.com/reports/transplant-diagnostics-market-1324
Transplant Diagnostics Market COVID 19 Analysis
Many large-scale firms and industries suffered due to the Covid-19 impact, except for healthcare and lifecare items. The lockdown and physical isolation rules have affected millions of small and large businesses. Due to the lockdown and physical separation, the transplantation diagnosis market experienced a minor decline following the epidemic. The pandemic has seriously hindered future growth, which has considerably impacted the predicted market value. On the other hand, the pandemic scenario is projected to subside in the following years. As a result, the market will continue to rise steadily in the following years. Growing understanding of the diagnostic accuracy and risk of transmission of SARS-CoV-2 in immunosuppressed individuals will continue to influence industry standards for solid organ transplantation during the COVID-19 pandemic. The market may have been significantly impacted during the epidemic due to the difficulties associated with organ transplantation.
Buy Now: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=1324
Transplant Diagnostics Market Segmentation
By Product & Service
The instruments segment will gain precedence over the other segments in the forecast period.
By Screening Type
The pre-Transplant segment will gain a significant stake in the forecast period.
By Organ Type
The kidney segment will take the lead for the duration of the forecast period.
Transplant Diagnostics Market Regional Insights
Because of improvements in the healthcare sector in the area, North America is predicted to dominate the global market throughout the forecast period. Furthermore, the United States is home to the most competent surgeons and innovative transplant technologies. Countries with well-funded organizations, infrastructure, and governmental participation in generating finances and awareness, such as the United States and Canada, are well-equipped to promote organ transplantation for patients.
Share your Queries @ https://www.marketresearchfuture.com/enquiry/1324
Intensifying endeavors from major industry players are projected to boost market growth even more. Europe will come in second, with a considerable share of the worldwide transplant diagnostics market. This is due to an increase in the frequency of organ transplants and donors and the government's support for the region's transplant diagnosis market. Over the projection period, the Asia-Pacific region is expected to have a remarkable market growth rate. The Asia-Pacific region has a huge patient population and well-developed healthcare infrastructure. Transplant diagnostics are in high demand due to the growing need for organ transplants. Furthermore, because of their potential, most transplant diagnostic producers and distributors place a greater emphasis on emerging markets. The rising prevalence of chronic diseases in developing countries drives increased attention to these areas.
Discover more research Reports on Healthcare Industry, by Market Research Future:
Surgical Chips Market Information by types (DNA Chips, brain chips, lab chips, protein chips, tissue chip) by application (Cancer Diagnosis and Treatment, Gene Expression, SNP Genotyping, Genomics, Clinical Diagnostics) , End users (hospitals, research centers, clinics, others) - Forecast to 2027
Optogenetic Market by product type (light instruments, actuators, sensors), by application (retinal diseases treatment, hearing problems treatment, neuroscience, and others), - Forecast to 2027
Biosimilars Market Research Report: By Product (Recombinant Non-Glycosylated Proteins (Human Growth Hormone [RHGH], Granulocyte Colony-Stimulating Factor [Filgrastim], Insulin and Interferons), Recombinant Glycosylated Proteins (Erythropoietin [EPO], Monoclonal Antibodies [MABS] and Follitropin) and Recombinant Peptides [Glucagon and Calcitonin]), by Applications (Oncology, Chronic Diseases, Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Infectious Diseases) - Forecast till 2030
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
